
CAS 180468-39-7: Solifenacin Hydrochloride
Formula:C23H27ClN2O2
InChI:InChI=1/C23H26N2O2.ClH/c26-23(27-21-16-24-13-10-18(21)11-14-24)25-15-12-17-6-4-5-9-20(17)22(25)19-7-2-1-3-8-19;/h1-9,18,21-22H,10-16H2;1H/t21-,22-;/m0./s1
SMILES:c1ccc(cc1)[C@H]1c2ccccc2CCN1C(=O)O[C@H]1CN2CCC1CC2.Cl
Synonyms:- (1S)-3,4-Dihydro-1-phenyl-2(1H)-isoquinolinecarboxylic Acid (3R)-1-Azabicyclo-[2.2.2]oct-3-yl Ester Hydrochlorid
- (1S)-3,4-Dihydro-1-phenyl-2(1H)-isoquinolinecarboxylic Acid (3R)-1-Azabicyclo-[2.2.2]oct-3-yl Ester Hydrochloride
- (3R)-1-azabicyclo[2.2.2]oct-3-yl (1S)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate hydrochloride (1:1)
Sort by
Found 6 products.
2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-1-phenyl-, (3R)-1-azabicyclo[2.2.2]oct-3-yl ester, hydrochloride (1:1), (1S)-
CAS:Formula:C23H27ClN2O2Purity:98%Color and Shape:SolidMolecular weight:398.9257Solifenacin-d7 Hydrochloride
CAS:Controlled ProductApplications Solifenacin-d7 hydrochloride is deuterium labelled Solifenacin hydrochloride (S676700), which is a Muscarinic M3 receptor antagoinst and used to treat urinary incontinence. References Ikeda K., et al.: Arch. Pharmacol., 366, 97, (2002), Chapple, C.R., et al.: Br. J. Urol., 93, 303 (2004), Ohtake, A., et al.: Eur. J. Pharmacol., 492, 243 (2004), Brunton, S., et al.: Curr. Med. Res. Opin., 21, 71 (2005), Habb, F., et al.: Eur. Urol. 47, 376 (2005), Payne, C.K., et al.: Drugs, 66, 175 (2006),Formula:C23H20D7ClN2O2Color and Shape:NeatMolecular weight:405.97Solifenacin hydrochloride
CAS:Solifenacin Hcl is a muscarinic receptor antagonist.Formula:C23H27ClN2O2Purity:98%Color and Shape:SolidMolecular weight:398.93(1S,3'R)-Solifenacin-d7 HCl(quinuclidinyl-d7)
CAS:Purity:98 atom % DColor and Shape:White SolidMolecular weight:405.97Solifenacin hydrochloride
CAS:Muscarinic receptor antagonistFormula:C23H27ClN2O2Purity:Min. 95%Molecular weight:398.93 g/molSolifenacin Hydrochloride
CAS:Controlled ProductFormula:C23H26N2O2·ClHColor and Shape:NeatMolecular weight:398.93